Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsclinical-pharmacology-and-therapeutics

Paeds SAQs · clinical-pharmacology-and-therapeutics

Inhaled therapies and device selection — formative SAQs

Formative SAQs on inhaled therapies and device selection in children: matching the device to the child's age and inspiratory flow using the age-based ladder, and defending the spacer-versus-nebuliser choice in acute asthma and the device-and-technique assessment of a 'failing' inhaled corticosteroid before escalating the dose.

20 marks30 min3 min readVerification in progress

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
On this page
Study tools

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
Prompt
Age-based device selection and the spacer-versus-nebuliser decision in acute asthma

SAQ 1 — Choosing the device across childhood (10 marks, 15 minutes)

Stem: A general paediatric clinic sees three children on the same morning: an eighteen-month-old with viral wheeze, a five-year-old with preschool wheeze, and a twelve-year-old with established asthma. Outline the age-based device ladder, the breath action expected at each step, and the principle that governs each transition. [1] [3]

Model answer

The ladder and the breath action (5 marks). The devices are matched to the child's age, inspiratory flow and coordination. The infant and toddler under about four years uses a pressurised metered-dose inhaler seated in a small-volume valved holding chamber with a tightly-fitting face mask; the dose is fired into the chamber and cleared by slow tidal breathing over around six breaths per actuation, the mask held firmly to the face. The preschool child, about four to six years, moves to a spacer with a mouthpiece, taking one to two slow deep breaths with a short breath-hold per actuation; a dry-powder inhaler is usually still too demanding. The school-age child, from about six years, can use a dry-powder inhaler if inspiratory flow is adequate — one sharp, deep inhalation then a breath-hold — or continue a spacer and pMDI. The adolescent, twelve years and over, can use any device, and the choice is increasingly driven by adherence. [1] [3]

The principle governing each transition (3 marks). Each step is a clinical judgement of the individual child, not a fixed birthday. The mask-to-mouthpiece transition depends on the child forming a reliable seal around the mouthpiece for the whole dose. The spacer-to-dry-powder-inhaler transition depends on generating the inspiratory flow — roughly thirty to sixty litres per minute — needed to de-aggregate the powder. A dry-powder inhaler given to a child who cannot generate that flow delivers almost nothing. [1] [3]

Teaching and review (2 marks). Technique is taught by demonstration and return-demonstration (teach-back) at every visit, because technique drifts and the child grows out of one device into another. After an inhaled corticosteroid the child rinses and spits to prevent oral candidiasis, and the dose counter is checked. [3]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References3ShowHide
  1. [1]Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest, 2005.PMID 15654001
  2. [3]van Aalderen WM, Garcia-Marcos L, Gappa M, et al. How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze. NPJ Primary Care Respiratory Medicine, 2015.PMID 25568979
  3. [5]Cates CJ, Welsh EJ, Rowe BH Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database of Systematic Reviews, 2013.PMID 24037768
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousImmunosuppressive and biologic therapies — formative SAQsclinical-pharmacology-and-therapeuticsNextMedication adherence and formulation challenges — formative SAQsclinical-pharmacology-and-therapeutics